ATE196925T1 - Menschlicher dopamin d4 rezeptor und seine verwendungen - Google Patents

Menschlicher dopamin d4 rezeptor und seine verwendungen

Info

Publication number
ATE196925T1
ATE196925T1 AT92902095T AT92902095T ATE196925T1 AT E196925 T1 ATE196925 T1 AT E196925T1 AT 92902095 T AT92902095 T AT 92902095T AT 92902095 T AT92902095 T AT 92902095T AT E196925 T1 ATE196925 T1 AT E196925T1
Authority
AT
Austria
Prior art keywords
receptor
human
dopamine receptor
human dopamine
cultures
Prior art date
Application number
AT92902095T
Other languages
English (en)
Inventor
Olivier Civelli
Tol Hubert Van
Original Assignee
Oregon State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon State filed Critical Oregon State
Application granted granted Critical
Publication of ATE196925T1 publication Critical patent/ATE196925T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • G01N33/9413—Dopamine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT92902095T 1990-12-07 1991-12-06 Menschlicher dopamin d4 rezeptor und seine verwendungen ATE196925T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/626,618 US5422265A (en) 1990-12-07 1990-12-07 DNA sequence for the human dopamine receptor D4 and expression thereof in mammalian cells
PCT/US1991/009308 WO1992010571A1 (en) 1990-12-07 1991-12-06 Human dopamine d4 receptor and its uses

Publications (1)

Publication Number Publication Date
ATE196925T1 true ATE196925T1 (de) 2000-10-15

Family

ID=24511138

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92902095T ATE196925T1 (de) 1990-12-07 1991-12-06 Menschlicher dopamin d4 rezeptor und seine verwendungen

Country Status (11)

Country Link
US (2) US5422265A (de)
EP (1) EP0574406B1 (de)
JP (1) JP2966093B2 (de)
AT (1) ATE196925T1 (de)
AU (1) AU652211B2 (de)
CA (1) CA2097698C (de)
DE (1) DE69132447T2 (de)
DK (1) DK0574406T3 (de)
FI (1) FI932573A (de)
NO (1) NO311363B1 (de)
WO (1) WO1992010571A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277591B1 (en) 1988-11-18 2001-08-21 Oregon Health Science University Dopamine receptors and genes
US5569601A (en) 1990-12-07 1996-10-29 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University Human dopamine receptor and its uses
CA2121256C (en) * 1991-10-16 2002-05-28 Kirston E. Koths Secreted mac-2-binding glycoprotein
US5766948A (en) * 1993-01-06 1998-06-16 The Regents Of The University Of California Method for production of neuroblasts
US6486310B1 (en) * 1993-01-28 2002-11-26 Washington University Gene encoding the rat dopamine D4 receptor
WO1994020497A1 (en) * 1993-03-01 1994-09-15 Merck Sharp & Dohme Limited Pyrrolo-pyridine derivatives
US5576319A (en) * 1993-03-01 1996-11-19 Merck, Sharp & Dohme Ltd. Pyrrolo-pyridine derivatives
US5622950A (en) * 1993-03-01 1997-04-22 Merck, Sharp & Dohme Ltd. Pyrrolo-pyridine derivatives
US5468615A (en) * 1993-07-01 1995-11-21 The Upjohn Company Binding assay employing a synthetic gene for D4 dopamine receptors
JPH09505727A (ja) * 1993-09-28 1997-06-10 アレリックス・バイオファーマスーティカルス・インコーポレーテッド 安定な細胞系統におけるヒトｄ４ドーパミンレセプターの発現
US5994503A (en) * 1995-03-27 1999-11-30 Yale University Nucleotide and protein sequences of lats genes and methods based thereon
US6531314B1 (en) * 1996-12-10 2003-03-11 Merck & Co., Inc. Growth hormone secretagogue receptor family
AU3230797A (en) * 1996-06-05 1998-01-05 Chiron Corporation Dna encoding dp. 75 and a process for its use
AUPO427596A0 (en) * 1996-12-20 1997-01-23 Cooperative Research Centre For Tropical Plant Pathology Anti-microbial protein
WO2000009538A2 (en) 1998-08-10 2000-02-24 Merck & Co., Inc. Canine growth hormone secretagogue receptor
US6783973B1 (en) 2000-09-12 2004-08-31 Oregon Health & Science University Mammalian catecholamine receptor genes and uses
US7381542B2 (en) * 2001-07-09 2008-06-03 Oregon Health & Science University Nucleic acids encoding a biogenic amine receptor
CA2607095A1 (en) * 2005-05-05 2006-11-09 Centre For Addiction And Mental Health Compositions and methods for modulating dopamine neurotransmission
ES2613866T3 (es) * 2008-06-12 2017-05-26 Centre For Addiction And Mental Health Composiciones y métodos para modular la interacción y la función del receptor de dopamina D1-D2

Also Published As

Publication number Publication date
FI932573A (fi) 1993-07-09
EP0574406B1 (de) 2000-10-11
NO311363B1 (no) 2001-11-19
US5422265A (en) 1995-06-06
DE69132447T2 (de) 2001-03-08
DE69132447D1 (de) 2000-11-16
JP2966093B2 (ja) 1999-10-25
CA2097698A1 (en) 1992-06-08
DK0574406T3 (da) 2000-11-13
NO932057D0 (no) 1993-06-04
NO932057L (no) 1993-08-09
US5594108A (en) 1997-01-14
FI932573A0 (fi) 1993-06-04
AU9140391A (en) 1992-07-08
WO1992010571A1 (en) 1992-06-25
AU652211B2 (en) 1994-08-18
EP0574406A1 (de) 1993-12-22
JPH06503958A (ja) 1994-05-12
CA2097698C (en) 1999-06-01

Similar Documents

Publication Publication Date Title
ATE196925T1 (de) Menschlicher dopamin d4 rezeptor und seine verwendungen
WO1994003602A3 (en) A novel human dopamine receptor and its uses
CA2133843A1 (en) Melanocyte stimulating hormone receptor and uses
WO1998006864A3 (en) Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat
ATE309378T1 (de) Abgeschwächter salmonellenstamm, gebraucht als vehikel zur oralen immunisierung
ATE553191T1 (de) Codon-optimierte alkalisch phosphatase und ihre expression in hefe
ES8604265A1 (es) Un metodo para preparar un peptido o una sal no toxica del mismo.
PT851926E (pt) Variantes do interferao-gama (rhu-ifn-gama) recombinante humano com estabilidade termica melhorada
EP0786995A4 (de)
HK1023143A1 (en) Intracellular production of hepatitis c e2 truncated polypeptid
TR200100426T2 (tr) Nematisit pirazoller
DK0856581T3 (da) Stabilt transficerede cellelinjer, der udtrykker GABA-A-receptorer
IL90334A0 (en) Genetic transformation of b.thuringiensis,vectors used therefor,host cells transformed by the vectors and use of said cells as insecticides
DK0843731T3 (da) Adenovirusvektorer til genterapi
MEP37808A (en) Dna encoding a novel rg1 polypeptide
NO800724L (no) Fremgangsmaate til fremstilling peptider med ubiquitinlignende aktivitet
CA2133845A1 (en) Adrenocorticotrophic hormone receptor and uses
AU1242188A (en) Isolation of single chain proteins with fsh suppressing activity from follicular fluid
DE69637628D1 (de) Episomaler vektor und dessen verwendung
HU9500619D0 (en) Cloning and expression of b-app-c100 receptor
TR199802387T2 (xx) Do�um kontrol� i�in kullan�lan Zona Pellucida proteinleri.
Bright Who owns indigenous peoples' DNA?
GB744460A (en) Improvements in or relating to electrical vibrators
DK336887A (da) Enzymer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee